| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972039 | The Journal of Heart and Lung Transplantation | 2009 | 7 Pages |
Abstract
Conversion to tacrolimus and atorvastatin appears to be a safe and effective lipid-lowering therapy in CsA-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Blanka MD, Milos MD, PhD, Ivan MD, PhD, Yevheniya MD, Lenka MD, Mariana MD, Josef MD, PhD,